Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice.
Depression remains underrecognized and undertreated worldwide, although it is a leading cause of disease burden. Many instruments are available to enhance the assessment of major depressive disorder (MDD) at 3 levels: screening, diagnosing, and monitoring treatment. This article reviews a variety of tools that can be used at each level of assessment as part of a measurement-based care approach to MDD. Measurement-based care for MDD is feasible in clinical practice. Patient self-reports can be used instead of clinician-rated scales to save time, whether in paper, computerized, or interactive voice response formats. Assessment tools are available in many languages. Treatment algorithms can rationalize decision making, and collaborative care can speed and enhance treatment results.
Gelenberg
Alan J
AJ
Healthcare Technology Systems, Inc, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, USA. agelenberg@Healthtechsys.com
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D003430:Cross-Sectional Studies; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D006801:Humans; D033183:Interdisciplinary Communication; D007406:Interview, Psychological; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data; D010555:Personality Inventory / Q000706:statistics & numerical data; D011320:Primary Health Care; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011594:Psychometrics; D011613:Psychotherapy; D015203:Reproducibility of Results; D013405:Suicide / Q000523:psychology; D011795:Surveys and Questionnaires; D014481:United States; D000092864:Suicide Prevention
D000928:Antidepressive Agents